[ad_1]
What volunteer AstraZeneca for the coronavirus vaccine, which showed symptoms of transverse myelitis, reveals to the Daily Mail
HE AstraZeneca announced Wednesday that its global tests were suspended vaccine against him coronavirus, which take place in many countries, following the appearance of a “Possibly unexplained illness” to a volunteer. This volunteer is said to have neurological symptoms associated with a rare inflammation of the spinal cord, called transverse myelitis.
In an exclusive interview on the website of the British newspaper “Daily Mail”, or voluntary admitted that you were vaccinated last May and within 14 hours of the vaccination you started to feel unwell. “He had a fever, headache and fatigue”, he says. However, he says he is “willing” to continue after his clinical trials resume. vaccine after the temporary suspension of the vaccine.
The British newspaper article states that debilitating side effects lasted for several days then. “I woke up around 2 in the morning and shuddered, but I had a fever over 39.” «I couldn’t really get up and move so my partner had to bring me some paracetamol.». “The high fever continued for another day and I felt very weak, I was lethargic, there was nothing I could do,” he said.
HEALTH
AstraZeneca: What is “icing” transverse myelitis in vaccine trials?
AstraZeneca: What is “icing” transverse myelitis in vaccine trials?
The volunteer adds that the most severe symptoms had disappeared on the third day after vaccination, but the side effects continued. “I still felt weak for a few days even though the symptoms weren’t as bad as the first day, which was terrible,” he said.
According to information from New York Times, citing a person familiar with the situation, one of the participants in the clinical trials of the experimental vaccine in Great Britain diagnosed with transverse myelitis, an inflammatory syndrome of the spinal cord often caused by viral infections. Does not have cleared up if the onset of the disease is associated with the AstraZeneca vaccine.
What does the pharmacy answer?
According to the BBC, the MHRA medical regulatory authority will make the final decision on resuming clinical trials within a few days. “This is a routine procedure that is followed when a potentially unexplained illness occurs in one of the tests,” he explained. AstraZeneca in its announcement of the cessation of testing.
AstraZeneca CEO Pascal Sorio says it is very common to suspend research on a vaccineBut this time the difference is that everyone is watching the developments closely.
“In fact, it is very common and many experts can tell you,” he said. “The difference with other clinical trials of vaccines is that not everyone is looking at them.” They stop, investigate and start again, “he explained. The owner of AstraZeneca clarified that the pharmacist does not know the clear diagnosis of the volunteer, adding that he is not of course she has developed transverse myelitis and further tests are needed.
Sorio pointed out that The diagnosis will be sent to an independent safety committee, which will inform the pharmaceutical company if it can continue with clinical trials. AstraZeneca will deliver the vaccines to the countries at the same time in order to ensure their fair and equitable distribution, said the head of the company. He added that the pharmaceutical industry is close to increasing its production capacity to 3 billion doses in laboratories around the world, in order to prevent governments from restricting the distribution of the vaccine.
The vaccine, developed by AstraZeneca in conjunction with the University of Oxford, was characterized by World Health Organization probably the world’s leading candidate vaccine against covid-19 and the most advanced in terms of its development.
